NASDAQ: VMDViemed Healthcare Inc Stock
$8.09+0.03 (+0.37%)
Updated Apr 24, 2024
VMD Price
$8.09
Fair Value Price
$11.16
Market Cap
$313.54M
52 Week Low
$5.90
52 Week High
$11.27
P/E
29.96x
P/B
2.75x
P/S
1.65x
PEG
26.5x
Dividend Yield
N/A
Revenue
$183.01M
Earnings
$10.24M
Gross Margin
61.6%
Operating Margin
8.1%
Profit Margin
5.6%
Debt to Equity
0.36
Operating Cash Flow
$45M
Beta
0.73
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
VMD Overview
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VMD ($8.09) is undervalued by 27.5% relative to our estimate of its Fair Value price of $11.16 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
VMD ($8.09) is significantly undervalued by 27.5% relative to our estimate of its Fair Value price of $11.16 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
VMD ($8.09) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VMD due diligence checks available for Premium users.
Be the first to know about important VMD news, forecast changes, insider trades & much more!
VMD News
Valuation
VMD fair value
Fair Value of VMD stock based on Discounted Cash Flow (DCF)
Price
$8.09
Fair Value
$11.16
Undervalued by
27.50%
VMD ($8.09) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VMD ($8.09) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VMD ($8.09) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
VMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.96x
Industry
30.46x
Market
41.27x
VMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
VMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
VMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.75x
Industry
3.73x
VMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
VMD price to earnings growth (PEG)
For valuing profitable companies with growth potential
VMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
VMD's financial health
Profit margin
Revenue
$50.7M
Net Income
$3.5M
Profit Margin
6.9%
VMD's Earnings (EBIT) of $14.82M... subscribe to Premium to read more.
Interest Coverage Financials
VMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$154.9M
Liabilities
$41.0M
Debt to equity
0.36
VMD's short-term assets ($38.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VMD's short-term assets ($38.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$13.3M
Investing
-$7.5M
Financing
-$3.0M
VMD's operating cash flow ($45.21M)... subscribe to Premium to read more.
Debt Coverage Financials
VMD vs Medical Device Stocks
Viemed Healthcare Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.